These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
270 related articles for article (PubMed ID: 26779435)
1. Bone Tumor Environment as a Potential Therapeutic Target in Ewing Sarcoma. Redini F; Heymann D Front Oncol; 2015; 5():279. PubMed ID: 26779435 [TBL] [Abstract][Full Text] [Related]
2. New Insights about the Wnt/β-Catenin Signaling Pathway in Primary Bone Tumors and Their Microenvironment: A Promising Target to Develop Therapeutic Strategies? Danieau G; Morice S; Rédini F; Verrecchia F; Royer BB Int J Mol Sci; 2019 Jul; 20(15):. PubMed ID: 31370265 [TBL] [Abstract][Full Text] [Related]
3. Bisphosphonates in common pediatric and adult bone sarcomas. Heymann MF; Lezot F; Heymann D Bone; 2020 Oct; 139():115523. PubMed ID: 32622877 [TBL] [Abstract][Full Text] [Related]
4. Targeting the tumor microenvironment of Ewing sarcoma. Morales E; Olson M; Iglesias F; Luetkens T; Atanackovic D Immunotherapy; 2021 Dec; 13(17):1439-1451. PubMed ID: 34670399 [TBL] [Abstract][Full Text] [Related]
5. Cutaneous Ewing Sarcoma and Ewing Sarcoma of the Bone: Distinct Diseases. Tavakkoli M; Mueller L Case Rep Oncol; 2018; 11(3):729-734. PubMed ID: 30519175 [TBL] [Abstract][Full Text] [Related]
6. The role of osteoclastic activity in prostate cancer skeletal metastases. Keller ET Drugs Today (Barc); 2002 Feb; 38(2):91-102. PubMed ID: 12532187 [TBL] [Abstract][Full Text] [Related]
7. Expression of CCL21 in Ewing sarcoma shows an inverse correlation with metastases and is a candidate target for immunotherapy. Sand LG; Berghuis D; Szuhai K; Hogendoorn PC Cancer Immunol Immunother; 2016 Aug; 65(8):995-1002. PubMed ID: 27369431 [TBL] [Abstract][Full Text] [Related]
8. Bone marrow involvement identifies a subgroup of advanced Ewing sarcoma patients with fatal outcome irrespective of therapy in contrast to curable patients with multiple bone metastases but unaffected marrow. Thiel U; Wawer A; von Luettichau I; Bender HU; Blaeschke F; Grunewald TG; Steinborn M; Röper B; Bonig H; Klingebiel T; Bader P; Koscielniak E; Paulussen M; Dirksen U; Juergens H; Kolb HJ; Burdach SE Oncotarget; 2016 Oct; 7(43):70959-70968. PubMed ID: 27486822 [TBL] [Abstract][Full Text] [Related]
9. Drugs targeting the bone microenvironment: new therapeutic tools in Ewing's sarcoma? Redini F; Odri GA; Picarda G; Gaspar N; Heymann MF; Corradini N; Heymann D Expert Opin Emerg Drugs; 2013 Sep; 18(3):339-52. PubMed ID: 23957761 [TBL] [Abstract][Full Text] [Related]